AZ appeals $215M Medicaid verdict

AstraZeneca asked an Alabama judge to toss out or reduce a $215 million jury verdict in a Medicaid drug price fraud lawsuit, saying that the state didn't prove that AstraZeneca deliberately caused the Medicaid system to overpay for drugs. A ruling is expected within 10 days. Report

Suggested Articles

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

Pfizer's Upjohn has reached a deal to exclusively supply generic Viagra to telehealth provider Roman as the company prepares to merge with Mylan.